In response to the ongoing hormone replacement shortages, the British Menopause Society has issued a further update on the current availability of HRT products. This provides guidance to clinical practitioners who may be experiencing difficulties with HRT supplies.
There continues to be availability issues with many HRT products, either related to manufacturing shortages or supply issues. The BMS has been informed that these are temporary shortages which pharmaceutical companies and their suppliers are addressing.
In the meantime, prescribers can continue to consider equivalent preparations that provide a similar dose to that which their patient is using. If an exact match is not possible, prescribers can seek guidance available on the practical prescribing chart on the BMS website and Menopause Matters website, to clarify equivalent doses.
Read the full update here.